First Human Trial of Potential COVID-19 Vaccine Underway in Australia
Wednesday, 27 May 2020 17:52 WIB | GLOBAL |Global

The southern hemisphere's first human trials of a potential coronavirus vaccine have started in Australia.  131 people aged between 18-59 are involved in the program in Melbourne and Brisbane.          

The potential vaccine, NVX-CoV2373, is being developed by the American biotech company Novavax. It started working on the drug in January when the COVID-19 outbreak began in China. It aims to boost the body's immune response and stimulate high levels of neutralizing antibodies. 

If the vaccine works, researchers hope 100 million doses can be made by the end of this year and 1.5 billion next year.

Researchers say that "vaccines are miracles and have a great way of protecting populations against these severe diseases."

Dr Paul Griffin is an infectious diseases expert who is involved in the Australian COVID 19 trial.  He hopes the drug will successfully attack the virus and be ready for use within months.  

"We look for antibodies and the type and number of antibodies, and then we take some things out of the subjects through those blood tests and do a lot of laboratory experiments to show that it neutralizes the virus.  The company manufacturing the vaccine have already started that scaling-up process, so they are already making a lot of doses of this vaccine.  So if we can prove it is safe and effective then, potentially, by the end of the year there will be significant number of doses available," Griffin said. 

Australian authorities say the trial is a significant step forward in the global race for a coronavirus vaccine.  Some participants will receive a placebo while others will be administered Novavax's drug.

Early results are expected in July, and scientists expect "some conclusive results by the end of this year".  Phase two trials would take place with thousands of volunteers in several countries.  Volunteers are still needed, and the research team has stressed that no live coronavirus is used in experiments on people.

Novavax has received $388 million from the Norway-based Coalition for Epidemic Preparedness Innovations.  There are more than 100 potential coronavirus vaccines in development, and about a dozen have made it to the human trial stage.  

It is a global race potentially worth billions of dollars to those who can find a safe and reliable treatment for a virus that has killed almost 350,000 people around the world.

Source : VOA

RELATED NEWS

Colombia Arrests 8 More Suspects in Police Academy Car Bombing
Saturday, 4 July 2020 01:40 WIB

Colombia has captured eight leftist rebels accused of killing at least 22 people in a bombing attack on a police academy. The National Liberation Army (ELN) claimed responsibility for the January 2019 car bombing in the capital Bogota. The rebel group claimed the attack was in retaliation for Presi...

US Senate Passes Bill Targeting Entities Over China's Hong Kong Security Law
Friday, 3 July 2020 17:34 WIB

The U.S. Senate approved a bill Thursday that would penalize individuals or companies for conducting business with Chinese officials responsible for implementing Beijing's new national security law on Hong Kong. The Republican-led Senate unanimously passed the Hong Kong Autonomy Act one day after t...

The Trump Administration Announces Plans to Celebrate Independence Day in the Capital
Friday, 3 July 2020 13:38 WIB

President Donald Trump's administration continues plans to hold a traditional July 4th independence day celebration in Washington DC, complete with massive fireworks displays, while the Covid-19 pandemic is taking place. The "Salute to America" ‹‹Celebration Plan announced on Wednesday (1/7) by...

Russian Voters Clear Path for Putin to Remain in Power Until 2036
Thursday, 2 July 2020 23:21 WIB

Voters in Russia have approved a package of constitutional reforms that includes opening the possibility that President Vladimir Putin can remain president until 2036.¯ Kremlin spokesman Dmitry Peskov said Thursday the result was a œtriumph. Opposition officials and independent election obs...

US, German Firms Say Possible COVID Vaccine Shows Encouraging Results
Thursday, 2 July 2020 17:43 WIB

Tests of a possible COVID-19 vaccine are showing encouraging results, U.S. and German scientists say. U.S.-based Pfizer and the German firm BioNTech have teamed up for what they call Project Lightspeed, whose goal is a vaccine against COVID-19. Both firms Wednesday announced "early positive data...

ANOTHER NEWS
Hong Kong Stocks End Week on Strong Note (Review)
Saturday, 4 July 2020 03:45 WIB Hong Kong shares ended higher Friday, extending the previous day's near-three percent gains, as global markets were boosted by a better-than-expected reading on US jobs creation. The Hang Seng Index jumped 0.99 percent, or 248.93 points, to...

DISCLAIMER

Seluruh materi atau konten yang tersaji di dalam website ini hanya bersifat informatif saja, dan tidak dimaksudkan sebagai pegangan serta keputusan dalam investasi atau jenis transaksi lainnya. Kami tidak bertanggung jawab atas segala akibat yang timbul dari penyajian konten tersebut. Semua pihak yang mengunjungi website ini harus membaca Terms of Service (Syarat dan Ketentuan Layanan) terlebih dahulu dan dihimbau untuk melakukan analisis secara independen serta memperoleh saran dari para ahli dibidangnya.